Tag: call

NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADSs”) of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 and July 28, 2024, both dates inclusive (the “Class Period”), of the important August 4, 2025 lead plaintiff deadline.

As consumer demand for clean beauty and functional supplements rises in 2025, marine collagen gummies like Pilly Labs are emerging as a preferred daily solution for supporting skin texture, joint mobility, and hair strength — all without powders, pills, or synthetic additives.

NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Fiserv, Inc. (NYSE: FI) between July 24, 2024 and July 22, 2025, both dates inclusive (the “Class Period”), of the important September 22, 2025 lead plaintiff deadline.

As the world fixates on cyber warfare, grid instability, and rising tensions in the Middle East, a quieter alarm is sounding beneath the headlines. It doesn’t come from mainstream media, but from former defense insiders and everyday Americans quietly preparing for a different kind of threat — one that won’t announce itself with sirens or headlines. That’s the driving force behind Dark Reset: Survival Before the Silence, a civilian resilience system based on the belief that the next collapse won’t start with fire — it’ll start with silence.

In 2025, conversations around energetic detox, pineal awakening, and stimulant-free cognitive clarity are dominating TikTok feeds, Google search spikes, and longform creator content. GoldAlign has become one of the most visible supplements mentioned in this evolving conversation — not for making bold promises, but for appearing alongside meditation stacks, awakening rituals, and spiritual wellness guides. With ingredients like Monoatomic Gold, Holy Basil, and Myrrh, it’s being observed as part of a broader movement: one that values natural alignment, plant-based intention, and clarity without stimulation.

In this 2025 GlobeNewswire release, Nutraville explores the spiritual science behind its Pineal Awakening formula — a clean-label blend of Himalayan Shilajit and synergistic botanicals gaining attention for its connection to pineal gland detox protocols, intuitive alignment, and ancient wellness systems. This educational report highlights the rising search behavior around “wealth resin,” pineal activation, and natural clarity tools.

Experts Reveal 2025 Dog Gut Health Findings, Ingredient Transparency Push, and the Rise of Targeted Canine Probiotics

NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Biohaven Ltd. (NYSE: BHVN) between March 24, 2023 and May 14, 2025, both dates inclusive (the “Class Period”), of the important September 12, 2025 lead plaintiff deadline.

NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of GeneDx Holdings Corp. (NASDAQ: WGS) resulting from allegations that GeneDx may have issued materially misleading business information to the investing public.

If you purchased or acquired securities in any of the above companies during their class period and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648

Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Marion Passmore Encourage Investors Who Suffered Losses In Hims To Contact Them To Discuss Their Options

Bragar Eagel & Squire, P.C. Litigation Attorney Brandon Walker Encourages Investors Who Suffered Losses In Bitfarms (BITF) or Reddit (RDDT) To Contact Him Directly To Discuss Their Options

NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Vera Bradley, Inc. (NASDAQ: VRA) resulting from allegations that Vera Bradley may have issued materially misleading business information to the investing public.